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Abstract
The molecular epidemiology of third-generation cephalosporin-resistant (3GC-R) Klebsiella pneumoniae in developing countries is poorly
documented. From February 2007 to March 2008, we collected 135 3GC-R K. pneumoniae isolates from seven major towns in Maghreb
(Morocco), West Africa (Senegal, Coˆte d’Ivoire), Central Africa (Cameroon), East Africa (Madagascar) and Southeast Asia (Vietnam).
Their genetic diversity, assessed by multilocus sequence typing, was high (60 sequence types), reﬂecting multiclonality. However, two
major clonal groups, CG15 (n = 23, 17% of isolates) and CG258 (n = 18, 13%), were detected in almost all participating centres. The
two major clonal groups have previously been described in other parts of the world, indicating their global spread. The high diversity of
enterobacterial repetitive intergenic consensus sequence-PCR banding patterns at the local level indicates that most isolates were
epidemiologically unrelated. The isolates were characterized by the presence of multiple resistance determinants, most notably the
concomitant presence of the aac(6¢)-Ib-cr, qnr and blaCTX-M-15 genes in 61 isolates (45%) belonging to 31 sequence types. These isolates
were detected across a large geographical area including Cameroon (n = 1), Vietnam (n = 4), Madagascar (n = 10), Coˆte d’Ivoire
(n = 12), Morocco (n = 13) and Senegal (n = 21). These results have major implications for patient management and highlight a potential
reservoir for resistance determinants.
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Introduction
Third-generation cephalosporin-resistant (3GC-R) Enterobac-
teriaceae have spread throughout the world, initially in the
hospital setting and more recently in the community. This
resistance is mainly mediated by acquired extended-spectrum
b-lactamase (ESBL) genes located on mobile genetic elements
such as plasmids or transposons [1]. This situation is of great
concern, as ESBL enzymes can hydrolyse almost all b-lactams
(except for carbapenems and cephamycins), and are fre-
quently associated with resistance genes against antimicrobial
agents of multiple families.
The ESBL-producing Klebsiella pneumoniae constitute one of
the most common multidrug-resistant groups of gram-negative
bacteria worldwide. CTX-M has emerged as the dominant
ESBL family in K. pneumoniae strains, although TEM and SHV
enzymes as well as members of the other three Ambler classes
of b-lactamases (B, C and D) are also common. Molecular
studies of ESBL isolates using multilocus sequence typing have
shown that the spread of ESBL-producing K. pneumoniae is
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largely multiclonal, contrary to KPC-producing isolates of this
species, which mainly belong to sequence type (ST) 258 or
related STs [2]. Few data on the population diversity of
K. pneumoniae strains and the antibiotic resistance genes they
harbour are available for Africa [3] and Southeast Asia [4]. This
information is important for understanding the global spread
of multidrug-resistant K. pneumoniae.
Here, we report the molecular characterization of 3GC-R
K. pneumoniae isolates collected in ﬁve African and two
Vietnamese major towns by means of multilocus sequence
typing and antimicrobial-resistance gene proﬁling.
Materials and Methods
Study population
Between February 2007 and March 2008, 135 non-duplicate
3GC-R K. pneumoniae were collected in 14 major health insti-
tutions (including ten hospitals) located in ﬁve major African
towns, namely Abidjan (Coˆte d’Ivoire), Antananarivo (Mada-
gascar), Casablanca (Morocco), Dakar (Senegal) and Yaounde
(Cameroon), and in two major towns in Vietnam (Southeast
Asia), namely Ho Chi Minh City and Hanoi. Written informed
consent was obtained from all the patients and the study
protocol was approved by local national ethics committees.
Microbiological analysis and DNA extraction
The isolates were identiﬁed with the API-20E system
(bioMe´rieux, Marcy L’Etoile, France) and conﬁrmed by
sequence analysis of the rpoB gene coding for the RNA polymer-
ase b-subunit, as previously described [5]. Genomic DNA was
extracted with the QIAmp kit (Qiagen, Courtaboeuf, France).
Antimicrobial susceptibility
Susceptibility to amoxicillin, ticarcillin, cefalotin, cefoxitin,
cefotaxim, ceftazidim, imipenem, gentamicin, tobramycin, kana-
mycin, amikacin, trimethoprim–sulphamethoxazol, ciproﬂoxacin
and fosfomycin was determined by the disc diffusion method on
Mueller–Hinton agar (Bio-Rad, Marnes La Coquette, France),
according to the guidelines of the French Society of Microbiol-
ogy. Production of ESBL was detected by the double-disc syn-
ergy test with an amoxicillin–clavulanic acid disc surrounded at
a radius of 20 mm by cefotaxim, ceftazidim and aztreonam discs.
External quality control was ensured by the French National
Antibiotic Reference Centre (Institut Pasteur, Paris, France).
Detection of b-lactamase and plasmid-mediated quinolone
resistance genes
Previously described PCR methods were used to screen
for genes encoding carbapenem-hydrolysing b-lactamases
(blaVIM, blaIMP and blaKPC), as well as plasmid-encoded
blaCTX-M, blaAmpC, blaSHV, blaTEM, blaGES, blaVEB, b-lactamase
genes, the aac(6¢)-Ib gene, and the quinolone resistance
qnrA/B/S/C/D and qepA genes [6–9]. Both blaCTX-M and
blaSHV were then characterized by direct DNA sequencing
of the PCR products, as was blaTEM for blaCTX-M and ESBL
blaSHV gene negative strains. All aac(6¢)-Ib-positive strains
were further analysed by digestion of the PCR product
with BtsCl (New England Biolabs, Ipswich, MA, USA) to
identify aac(6¢)-Ib-cr, which lacks the BtsCl restriction site
present in the wild-type gene [10]. Isolates resistant to
cefoxitin were tested for the presence of six families of
plasmid-borne ampC genes (FOX, ACC, EBC, MOX, CIT,
DHA) [11] and blaCMY-2.
Multilocus sequence typing and enterobacterial repetitive
intergenic consensus sequence-PCR
Multilocus sequence typing was performed as described else-
where [5,12]. In order to assess the degree of clonal rela-
tionships between isolates at local level, enterobacterial
repetitive intergenic consensus sequence (ERIC) -PCR was
performed on strains assigned to the same ST isolated in the
same town. Strains with an identical ERIC-PCR banding pat-
tern were deﬁned as related.
Results and Discussion
Bacterial strains and antimicrobial susceptibility
A total of 135 3GC-R K. pneumoniae isolates were collected
during the study period. Twelve isolates (9%) were recov-
ered in Antananarivo (Madagascar), 13 (10%) in Yaounde
(Cameroon), 17 (13%) in Casablanca (Morocco), 22 (16%) in
Abidjan (Coˆte d’Ivoire), 31 (23%) in Vietnam (15 in Ho Chi
Minh City and 16 in Hanoi) and 40 (30%) in Dakar (Senegal;
Fig. 1). Forty-six isolates (34%) were associated with urinary/
genital tract infections, 44 (32%) with wound infections, 31
(23%) with bacteraemia/septicaemia, 13 (10%) with
pulmonary infection and one with diarrhoea. No signiﬁcant
association was observed between the genetic background of
the isolates (see next section) and the type of infection (data
not shown). All K. pneumoniae isolates were resistant to all
the b-lactams tested, except for cefoxitin (7% resistance,
n = 10), and all were susceptible to imipenem. In addition,
they were characterized by high rates of resistance to
tobramycin (99%), gentamicin (84%), ciproﬂoxacin (87%) and
cotrimoxazole (90%), and high rates of susceptibility to
amikacin (64%), kanamycin (71%) and fosfomycin (99%). The
double-disc synergy test was positive only for strains
susceptible to cefoxitin.
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Genetic background of K. pneumoniae isolates and identiﬁca-
tion of two widespread clonal groups
The 135 K. pneumoniae isolates belonged to 60 STs (see Sup-
plementary material, Table S1), in keeping with the high
genotypic diversity of this species [5,12]. To deﬁne groups of
related STs, we ﬁrst deﬁned clonal complexes (CC) using
the most stringent criterion, i.e. as groups of STs differing by
a single allelic mismatch relative to at least one other mem-
ber of the group. Singletons were deﬁned as STs that were
not grouped into CCs, i.e. differing by at least two allelic
mismatches from any other ST. As the composition and dis-
tinctness of CCs is highly dependent on the sample, we
attempted to link the CCs identiﬁed in the present study
with those found in the global multilocus sequence typing
database (http://www.pasteur.fr/mlst), that contained 650 STs
(as of 12 September 2011). This large dataset resulted in the
identiﬁcation of 62 CCs and 302 singletons. However, the
largest CC contained 139 STs, in a heterogeneous and strag-
gly CC, probably resulting from the merging of unrelated
STs because of the high rate of homologous recombination
[12,13], rather than from diversiﬁcation from a single com-
mon ancestor. Therefore, to deﬁne epidemiologically more
meaningful groups of STs, we deﬁned clonal groups (CGs) as
subsets of this large CC that included (i) one central geno-
type; (ii) its single-locus variants (ﬁrst circle SLVs); and (iii)
the SLVs of the ﬁrst-circle SLVs. The CGs were named
according to the central ST that was chosen for their deﬁni-
tion (e.g. CG258 includes ST258 as its central genotype, plus
the SLVs of ST258, plus their SLVs).
Using this deﬁnition, the 60 identiﬁed STs were assigned
to 25 CGs and 20 singletons (see Supplementary material,
Table S1), in keeping with the previously described multiclo-
nal spread of ESBL isolates. Only two CGs included more
than six strains: CG15 (n = 23, 17%) and CG258 (n = 18,
13%; see Supplementary material,Table S1; Fig. 1). Other fre-
quent groups of isolates were CG394 (n = 5), CG395
(n = 5), CG17 (n = 6), CG42 (n = 6) and one singleton,
ST70 (n = 6).
The two major CGs recovered in our study shared signiﬁ-
cant features (Table 1): (i) detection in at least ﬁve partici-
pating centres, indicating their wide geographical distribution;
(ii) high diversity of ERIC-PCR banding patterns at the local
level, indicating that most of the strains were epidemiologi-
cally unrelated; (iii) high prevalence of the CTX-M-15 b-lac-
tamase gene (83% for CG15 and 60% for CG258); and (iv)
high rate of resistance to most of the antibiotics tested,
apart from fosfomycin for both CGs (4% for CG15 and 5%
for CG258) and amikacin (22%) and kanamycin (5%) for
CG258.
The ﬁrst major clonal group, CG15, was composed solely
of ST15 isolates, plus a single ST14 isolate. ST15 is a wide-
spread ST previously described in Europe (Denmark and
Hungary) [14,15] and Asia (Korea, Malaysia, Singapore and
Taiwan) [4]. It was detected in ﬁve of the seven towns in
the present study, namely Antananarivo (Madagascar, n = 1),
Abidjan (n = 3, two unrelated strains) and Dakar (n = 11, six
unrelated strains) in West Africa; Yaounde (n = 5, four unre-
lated strains) in Central Africa; and Hanoi (two unrelated
strains) in Southeast Asia (Fig. 1). It was dominant in Dakar
(28% of all isolates) and Yaounde (38%; Table 1).
The second major clonal group, CG258, comprised
isolates belonging mainly to ST340 (n = 11, 61%) and ST11
FIG. 1. Distribution of third-generation cephalosporin-resistant Klebsiella pneumoniae in ﬁve African and two Vietnamese major towns. The pro-
portions of clonal groups at each sampling location are displayed as pie charts, with size indicating the number of isolates.
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(n = 5, 28%). It was detected in all the participating centres,
apart from Casablanca, and was the dominant clone in An-
tananarivo (33%). Interestingly, ST258, the central genotype
of CG258, which has been reported in the Americas, Europe
and Asia, was not found in our study [4,16,17]. In contrast,
ST340, found in Antananarivo (four strains, of which three
were unrelated), Dakar (six strains, of which ﬁve were unre-
lated) and Hanoi (n = 1), has rarely been described else-
where [4]. ST11 was detected at four sites in our study,
namely Abidjan (two unrelated strains), Yaounde (n = 1), Ha-
noi (n = 1) and Ho Chi Minh City (n = 1). This ST is cur-
rently prevalent in China, Korea [18] and Hungary [14] and
has also been detected in Brazil [19] and in several countries
in Europe [17] and Asia [4].
Clonal group CG258 is a major cause of multidrug-resis-
tant K. pneumoniae infections worldwide, but its evolutionary
emergence is poorly documented. ST11 and ST340 differ
from each other and from ST258 by only a few (two to four)
nucleotide changes in their tonB alleles. First isolated in 2008
[16], ST258 has almost always exhibited carbapenem resis-
tance, to the best of our knowledge, whereas ST11, isolated
as early as 1997, has been associated with ESBL production
but rarely with carbapenem resistance. Furthermore, the
tonB allele of ST258 (tonB-79) is only observed in six CG258
STs that are closely related to ST258 (including ST340) and
that were identiﬁed recently, whereas the tonB allele of ST11
(tonB-4) is widely distributed in 76 unrelated STs that include
strains isolated over several decades (http://www.pasteur.fr/
mlst). We infer that ST258 probably arose from ST11 by
acquisition of the tonB-79 allele, followed by acquisition of
carbapenem-resistance genes on mobile elements. More sam-
pling and higher-resolution genotyping are necessary to
retrace the emergence of this clonal group.
The remaining CGs and singletons identiﬁed herein have
previously been detected sporadically in other parts of the
world. Interestingly, we identiﬁed four strains belonging to
ST23 (CC23; one in Vietnam, and two in Madagascar, of
which two were unrelated) associated with surgical site
infections. This ST belongs to a well-known clone that causes
liver abscesses, mainly in Asia but also in Europe and Africa
[12,20,21].
Resistance determinants
CTX-M-15 was detected in 100 (74%) of the 135 isolates
tested, belonging to 42 of the 60 STs. It was detected at all
sites and was the dominant ESBL among the African isolates
(Table 1). CTX-M-14 and CTX-M-27 were also detected in
strains from Vietnam, in keeping with a previous report [22].
CTX-M-15 ESBL, ﬁrst detected in 1999 in India, is currently
recognized as the most widely distributed CTX-M b-lactam-
ase [1], even on the African continent [3]. Of the 89 SHV-
producing K. pneumoniae isolates, only seven strains were
ESBL-SHV-positive: SHV-5 (n = 3), SHV-27 (n = 2) and SHV-
2 (n = 2), with two strains each harbouring SHV-5 and CTX-
M-15. TEM typing was only performed on seven strains that
were both CTX-M-negative and ESBL-SHV-negative, and all
expressed the non-ESBL TEM-1. Among the ten strains that
were resistant to cefoxitin, seven were positive for DHA-1
(one in Abidjan, two in Casablanca and four in Hanoi) and
three for CMY-2 (Dakar). In all, 17 (13%) strains resistant to
third-generation cephalosporins with a positive double-disc
synergy test were negative for the tested ESBL, suggesting
the presence of ESBL OXA or unknown b-lactamases.
The aac(6¢)-Ib gene was detected in 95 (70%) of the 135
isolates, of which 84 (88%) were the cr variant. The qnr gene
was present in 115 isolates (85%) and qepA in one isolate
from Ho Chi Minh City (ST244). Seventy-one (97%) of the
73 strains carrying both qnr and aac(6¢)-Ib-cr were resistant
to ciproﬂoxacin. This combination was frequent in all sites,
which is a major concern because these two mechanisms act
additively. Among the 115 qnr-positive strains, 73 were qnrB,
41 were qnrS and ﬁve were qnrA, with four strains each har-
bouring two qnr genes. The qnrB was predominant among
strains from Africa (apart from Casablanca) and qnrS was
predominant among strains from Vietnam. Genes qnrC and
qnrD were not detected.
Sixty-one (45%) isolates, belonging to 31 (52%) of the 60
STs, carried the aac(6¢)-Ib-cr, qnr and blaCTX-M-15 genes. They
were detected over a large geographical area, including Ho
Chi Minh City (n = 4), Yaounde (n = 1), Antananarivo (n =
10), Casablanca (n = 13), Abidjan (n = 12) and Dakar (n = 21).
Reservoir for ESBL and other resistance determinants
A worrying prevalence of ESBL-producing Enterobacteriaceae
has been observed in all developing countries for which data
are available. For example, ESBL producers accounted for
5.2% of community-acquired urinary tract infections caused
by Escherichia coli in Senegal [23], 19.3% of Enterobacteriaceae
in the Central African Republic [24], 32.9% of Enterobacteria-
ceae in Tanzania [25], 26.9% of Enterobacteriaceae in India
[26] and 36.6% of E. coli in Cambodia [27]. In addition, as
carbapenems are often the most effective antibiotics used
against 3GC-R Enterobacteriaceae, the emergence of carbape-
nem resistance, a phenomenon that has been described in
Africa [28], but that was not found in our study, could
become a serious challenge for infection control and antibi-
otic therapy in the future.
The potential role of K. pneumoniae and other Enterobacte-
riaceae as a reservoir for ESBL genes and other resistance
determinants is a clear cause of concern in countries with
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inadequate healthcare systems. Key factors that favour the
spread of antimicrobial resistance in these countries include
uncontrolled consumption of antimicrobial agents through
self-medication, inappropriate antibiotic prescription, the sub-
standard quality of some drugs, and a lack of effective mea-
sures to prevent nosocomial infections. The virtual lack of
physical barriers between the community and hospital set-
tings in these countries may be an important contributory
factor, along with poor living conditions [29].
Conclusions
This study shows that even though the spread of multidrug-
resistant K. pneumoniae in Africa and Vietnam is mainly mul-
ticlonal, two major clonal groups, CG15 and CG258, cause
infections in most sites. Even though our ﬁndings may not be
representative of the overall situation of these countries, it is
noteworthy that this study took place in the main health insti-
tutions of each country. Clonal groups CG15 and CG258,
associated with multidrug resistance, have now been exten-
sively described in other parts of the world. Their widespread
geographical distribution is a major concern, both as a source
of therapeutic failure and as a potential reservoir of resis-
tance determinants. Human mobility may be the main factor
in the spread of multidrug-resistant K. pneumoniae clones, as
illustrated by the spread of NDM-1-producing strains from
India and Pakistan to the UK [30]. Analysis of the allelic diver-
sity within CG258 suggested that the widespread carbape-
nem-resistant genotype ST258 derived from an ST11
ancestor. High-resolution genotyping studies of isolates col-
lected over larger spatial and temporal scales will be neces-
sary to decipher the dynamics of the emergence of
multidrug-resistant K. pneumoniae clonal groups.
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